PERSPECTA

News from every angle

← Back to headlines

Lulu's and Journey Medical Forecast Positive 2026 EBITDA

Lulu's and Journey Medical have both announced projections for positive adjusted EBITDA in 2026. Lulu's plans a $2.0M-$2.5M capital expenditure, while Journey Medical intends to add up to five sales professionals.

13 May, 23:51 — 13 May, 23:51
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed1d ago

Lulu’s anticipates positive adjusted EBITDA in 2026 with $2.0M-$2.5M capex plan

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

Poland's April Inflation Reaches Ten-Month High

15m ago

Global Wealth Transfer of $84 Trillion Expected Over Two Decades

17m ago

Hungary's NER-Linked Companies Face Potential Restructuring and Ownership Changes

18m ago